ArticleScientific reports2025
Burden of multi-drug resistant bacterial isolates and its associated risk factors among UTI-confirmed geriatrics in Gondar town.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Prevalence of multidrug-resistant uropathogens isolated from patients with urinary tract infections in a tertiary hospital in Ghana.BMC microbiology · 2026Article
- Biofilm Formation, Virulence-Associated Genes, and Antimicrobial Resistance inMicroorganisms · 2026Article
- Synergistic antimicrobial and antibiofilm effects of mycosynthesized MnO-MgO bimetallic nanoparticles against drug-resistant pathogens.BMC microbiology · 2026Article
- Recurrent Urinary Tract Infections in a Patient with Diffuse Large B-Cell Lymphoma and Severe COVID-19: A Single Case of Suspected Immunosuppression Where Antibacterial Therapy Was Not Enough.Antibiotics (Basel, Switzerland) · 2026Article
- Determinants of multidrug-resistant urinary tract infections: A retrospective cross-sectional study from a tertiary care hospital in southern Bangladesh.PLOS global public health · 2026Article
- Article
- Evaluation of a bivalent vaccine composed of iron scavenger receptors PMI1426 and PMI1945 againstFuture microbiology · 2025Article
- Article
- Treatment gaps and risk factors for multidrug-resistant Enterobacterales in Belize: a 6-year (2018-2023) nationwide retrospective analysis.Therapeutic advances in infectious diseaseArticle
- The interplay between chronic kidney disease and urinary tract infections: a comprehensive review on the pathophysiological insights, interconnected burdens, and prevention strategies.Therapeutic advances in infectious diseaseReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multi-drug resistant (MDR) bacterial urinary tract infection (UTI) is a significant health threat in the geriatric population, with limited data in this study area. Therefore, this study aimed to assess the burden of MDR bacterial isolates and associated risk factors among UTI-confirmed geriatrics in Gondar, providing essential information for geriatric patients, healthcare workers, scientists, and policymakers to guide antibiotic stewardship interventions. A prospective cross-sectional study was conducted among 204 UTI-confirmed geriatrics. Socio-demographic data were collected via a structured questionnaire, and bacterial identification and drug resistance testing followed standard microbiological techniques. Data were entered using Epi Data version 4.0.0 and analyzed by Stata/IC version 14.0, with bivariate and multivariate logistic regressions to identify risk factors. A P-value < 0.05 was considered statistically significant. The overall prevalence of MDR UTI-confirmed geriatrics and MDR bacterial isolates were 115 (56.4%) and 126 (49.6%), respectively. The MDR Gram-negative isolates accounted for 105 (83.3%), and Gram-positive isolates 21 (16.7%). The predominant MDR bacterium was E. coli 60 (47.6%), followed by K. pneumoniae 24 (19.1%), S. aureus 13 (10.3%), P. mirabilis and S. saprophyticus 8 (6.4%), Pseudomonas spp. 6 (4.8%), P. vulgaris 4 (3.2%) and K. rhinos 3 (2.4%). Extensive (XDR) and pan-drug resistant (PDR) isolates were 63 (24.8%) and 6 (4.8%), respectively. Risk factors such as recurrent UTI, hospitalization (≥ 4 days), antibiotic and urinary catheter use were statistically significant. This study found a high prevalence of MDR bacterial isolates in UTI-confirmed geriatrics, with most isolates resistant to tetracycline, beta-lactams, and quinolones. Escherichia coli was the most common MDR and XDR bacteria, while Pseudomonas was the only PDR isolate. Independent risk factors included recurrent UTI, hospitalization (≥ 4 days), antibiotic and urinary catheter use. Therefore, efforts should focus on reducing hospital stays, promoting rational drug use, and further research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.